Articles |
From the Department of Physiology and Biophysics, Louisiana State University Medical Center, Shreveport, and Alkermes, Inc, Cambridge, Mass.
Correspondence to Dr D. Neil Granger, Department of Physiology and Biophysics, LSU Medical Center, 1501 Kings Hwy, PO Box 33932, Shreveport, LA 71130-3932. E-mail dgrang{at}lsumc.edu
| Abstract |
|---|
|
|
|---|
Key Words: vascular permeability selectins ß2 integrins mast cells
| Introduction |
|---|
|
|
|---|
We also examined the effect on oxLDL-induced inflammatory responses of a novel bacterial peptide (herein called F20) derived from the FHA of Bordetella pertussis.9 FHA promotes bacterial adherence to human monocytes/macrophages through an interaction with CD11b/CD18.10 11 12 This complex bacterial adhesin, which contains the eukaryotic cell adhesion motif Arg-Gly-Asp (RGD), appears to structurally and functionally mimic one or more cell adhesion molecules. Some evidence suggests that the RGD sequence on FHA mediates the aforementioned bacterial adherence to monocyte CD11b/CD18 through an interaction with a leukocyte signal-transduction complex.11 12 This receptor pair, called LRI and IAP, recognizes RGD and regulates some integrin functions.13 14 15 A 20-mer FHA peptide containing the RGD triplet (F20) has been shown to modulate ligand binding by CD11b/CD18 on leukocytes in a manner similar to that seen with antibodies against LRI/IAP.9 11 This bacterial peptide inhibits leukocyteendothelial cell adhesion in vitro and impedes recruitment of leukocytes into cerebrospinal fluid of animals with experimental meningitis.9
Previous studies have shown that the oxLDL-induced recruitment of rolling, firmly adherent, and emigrated leukocytes is accompanied by an enhanced rate of albumin extravasation from postcapillary venules as well as an increased number of degranulated mast cells in the adjacent perivenular interstitium.5 On the basis of experiments demonstrating an attenuating action of nitric oxidedonating agents on oxLDL-induced leukocyteendothelial cell adhesion, albumin leakage, and mast cell degranulation, it has been suggested that these temporally related intravascular and extravascular inflammatory reactions may be mechanistically linked. Hence, a second objective of the present study was to determine whether inhibiting the recruitment of adherent and emigrated leukocytes with MABs directed against adhesion molecules leads to an attenuation of the enhanced albumin leakage and mast cell degranulation elicited by oxLDL.
| Methods |
|---|
|
|
|---|
Surgical Procedure
Seventy-five male Sprague-Dawley rats (200 to 250 g) were
maintained on a purified laboratory diet and fasted for 24 hours before
each experiment. The animals were initially anesthetized with an
intraperitoneal injection of 140 mg thiobutabarbital (Inactin) per
kilogram of body weight. A tracheotomy was performed on each rat to
facilitate breathing throughout the experiment. The right carotid
artery was cannulated, and systemic arterial pressure was measured with
a Statham P23A pressure transducer connected to the carotid artery
cannula. Systemic blood pressure and heart rate were continuously
recorded with a Grass Instruments physiological recorder. A midline
abdominal incision was made to allow a section of mesentery from the
small intestine to be exteriorized. The aorta was cannulated with the
tip of the cannula placed at the bifurcation of the SMA. The left
jugular vein was also cannulated for drug administration. All exposed
tissue was moistened with saline-soaked gauze to minimize evaporation
and tissue damage.
Intravital Microscopy
Rats were placed in a supine position on an adjustable acrylic
plastic microscope stage, and the mesentery was prepared for
microscopic observation as described previously.21
Briefly, the mesentery was draped over a nonfluorescent coverslip that
allowed for observation of a 2-cm2 segment of tissue. The
exposed bowel wall was covered with Saran Wrap (Dow Chemical Co), then
the mesentery was superfused (bathed at a constant rate) with BBS
(37°C, pH 7.4) that was bubbled with a mixture of 5%
CO2, 95% N2, which exposes mesenteric tissue
to an oxygen tension of
40 mm Hg.
An inverted microscope (Diaphot 300, Nikon) with a 40x objective lens (Fluor; Nikon) was used to observe the mesenteric microcirculation. The mesentery was transilluminated with a 12-V, 100-W direct currentstabilized light source. A video camera (VK-C150; Hitachi) mounted on the microscope projected the image onto a color monitor (PMV-2030; Sony), and the image was recorded by use of a videocassette recorder (BR-S601MU; JVC). A video time-date generator (WJ810; Panasonic) projected the time, date, and stopwatch functions onto the monitor.
Single unbranched venules with diameters ranging between 25 and 35 µm and length >150 µm were selected for study. Venular diameter was measured either on-line or off-line with a video caliper (Microcirculation Research Institute, Texas A&M University). RBC centerline velocity was measured in venules with an optical Doppler velocimeter (Microcirculation Research Institute). The velocimeter was calibrated against a rotating glass disk coated with RBCs. Venular blood flow was calculated from the product of mean RBC velocity (Vmean=Centerline Velocity/1.6)22 and microvascular cross-sectional area, assuming cylindrical geometry. Wall shear rate (¥) was calculated on the basis of the newtonian definition: ¥=8(Vmean/D), where D is diameter.
The number of adherent leukocytes was determined off-line during
playback of the videotaped images. A leukocyte was considered to be
adherent to venular endothelium if it remained stationary for a period
30 seconds.23 Adherent leukocytes were expressed as the
number per 100 µm length of venule. The number of emigrated
leukocytes was also determined off-line during playback of videotaped
images. Any interstitial leukocytes present in the mesentery at the
onset of the experiment were subtracted from the total number of
leukocytes that accumulated during the course of the experiment.
Leukocyte emigration was expressed as the number per microscopic field
(2.12x10-2 mm2). Rolling
leukocytes were defined as those white blood cells that moved at a
velocity less than that of RBCs in the same stream of blood. The flux
of rolling leukocytes (FWBC) was determined by the number
of rolling leukocytes that crossed a point within a given period of
time. FWBC was expressed as the number of leukocytes per
second. Leukocyte rolling velocity (VWBC) was determined
from the time required for a leukocyte to roll a given distance along
the length of the venule. The number of rolling leukocytes per 100
µm venule length was calculated as
FWBC/VWBC.24 To visualize mast
cells surrounding the mesenteric microvasculature, 0.1 g% toluidine
blue was added onto the mesentery at the end of each
experiment.25 The number of intact and degranulated mast
cells was determined, and the percentage of degranulated mast cells was
calculated.
To quantify albumin leakage across mesenteric venules, 50 mg/kg of FITC-labeled bovine albumin (Sigma Chemical Co) was administered intravenously to the animals 15 minutes before each experiment.5 26 Fluorescence intensity (excitation wavelength, 420 to 490 nm; emission wavelength, 520 nm) was detected with a silicon-intensified target camera (C2400-08, Hamamatsu Photonics). The fluorescence intensity of FITC-albumin within three segments of the venule under study and in three contiguous areas of perivenular interstitium within 10 to 50 µm of the venular wall was measured at various times after administration of FITC-albumin with a computer-assisted digital imaging processor (NIH Image 1.35 on a Macintosh computer, Quadra 840AV). An index of vascular albumin leakage was determined from the ratio of interstitial to venular intensity of FITC-albumin fluorescence at specific intervals (10 minutes) after infusion of oxLDL. All data presented for albumin leakage represent this ratio at 30 and 60 minutes after injection of oxLDL.5 26
Experimental Protocols
After all parameters measured on-line were in a steady state,
images from the mesenteric preparation were recorded on videotape for
10 minutes. Immediately thereafter, either nLDL or oxLDL was infused
into the SMA at a rate of 1 mg LDL
protein·kg-1·min-1
for 5 minutes with the mesentery superfused with BBS (2 mL/min), and
repeat measurements were obtained at regular intervals for 60 minutes.
In some experiments, the same protocol was used but the animals were
pretreated (15 minutes before control measurements) with an MAB
directed against either CD18 (CL26, 100 µg per rat),27
ICAM-1 (IA29, 2 mg/kg),28 29 L-selectin (HRL3, 1
mg/kg),30 P-selectin (PB1.3, 2 mg/kg),31 or a
nonbinding antibody for P-selectin (P-23, 2 mg/kg).32 At
the doses used, none of the MABs caused leucopenia. Another group of
experiments tested peptide F20 (RGDPHQGVLAQGDIIMDAKG, corresponding to
residues 1097 to 1116 of the FHA of Bordetella
pertussis9 ; custom synthesized at QCB, Inc) and
peptide F23 (IDNPQHGGAMRDLGIAGGKD, scrambled version of F20; QCB, Inc).
A single peptide was added to the superfusate at the beginning of the
experiment, and the concentration was maintained at 50 µmol/L
throughout the entire experiment. In addition, a bolus (200 µg) of
either F20 or F23 was injected into the rat SMA 5 minutes after the
infusion of oxLDL. Otherwise, the same protocol as used with the MABs
was followed. All mean values presented herein represent data derived
from 6 animals, except for the control and oxLDL-treated groups, which
consisted of 12 animals each, and the nLDL-treated group, which
consisted of 9 animals.
Statistics
The data obtained in this study are expressed as mean±SE. The
data were analyzed by the use of standard statistical analysis, ie,
one-way ANOVA with Scheffé's post hoc test and Student's
t test. Statistical significance was set at
P<.05.
| Results |
|---|
|
|
|---|
|
A similar pattern of effectiveness in reducing leukocyte emigration was
observed with the different MABs (Fig 2
); ie, MABs
against leukocyte adhesion molecule CD18 and L-selectin reduced
emigration by 81% and 58%, respectively, whereas MABs against
endothelial cell adhesion molecule ICAM-1 and P-selectin reduced
emigration by 71% and 55%, respectively. The nonbinding MAB had no
effect.
|
Table 1
summarizes the effects of the different MABs and
peptides on the recruitment of rolling leukocytes elicited by oxLDL.
Although infusion of either nLDL or oxLDL increased the number of
rolling leukocytes, only oxLDL elicited a significant response. The
oxLDL-induced recruitment of rolling leukocytes was significantly
reduced by pretreatment with MABs against either CD18 (85% at both 30
and 45 minutes after oxLDL infusion) or ICAM-1 (81% and 80%,
respectively) but not P-selectin, L-selectin, or a nonbinding antibody.
Peptides F20 and F23 failed to alter the rolling response to oxLDL.
|
Fig 3
illustrates that the oxLDL-induced increase in
albumin leakage across postcapillary venules was significantly
attenuated by MABs directed against CD18 (74% to 76%), ICAM-1 (57%
to 80%), and P-selectin (69% to 76%) at both 30 and 60 minutes after
the infusion of oxLDL. The L-selectin and nonbinding MABs did not
reduce oxLDL-induced albumin leakage.
|
Fig 4
summarizes the effects of different MABs on the
mast cell degranulation response observed 60 minutes after infusion of
oxLDL. The oxLDL-induced mast cell degranulation was significantly
attenuated by pretreatment with MABs against CD18, ICAM-1, or
P-selectin (by 83%, 37%, and 62%, respectively). However, no
significant changes in mast cell degranulation were noted in animals
pretreated with either an L-selectinspecific MAB or a nonbinding
MAB.
|
Table 2
summarizes the effect of peptides F20 and F23 on
leukocyte adhesion, emigration, and mast cell degranulation induced by
oxLDL. Peptide F20 significantly reduced oxLDL-induced leukocyte
adherence (53%) and mast cell degranulation (59%) at 60 minutes after
oxLDL infusion, whereas the scrambled control peptide F23 had no
effect. Neither peptide significantly affected oxLDL-induced leukocyte
emigration.
|
Venular diameter, RBC velocity, and wall shear rate were not
significantly altered by any treatment (Table 3
),
indicating that the protective effects exerted by some of the different
MABs and by peptide F20 were not secondary to microhemodynamic changes.
Systemic blood pressure was also unaffected by infusion of either nLDL
or oxLDL.
|
| Discussion |
|---|
|
|
|---|
The leukocyte and endothelial cellsurface glycoproteins that mediate
the adhesive interactions induced by oxLDL have been studied using
endothelial cell monolayers exposed to oxLDL. oxLDL elicits an
increased adherence of neutrophils to endothelial cell monolayers that
is inhibited by MABs directed against either the
- (CD11a
and CD11b) or ß-subunits (CD18) of the leukocyte adhesion
glycoprotein complex CD11/CD18.34 The inhibitory effects
of the individual CD11a- and CD11b-specific MABs were less than that
observed after immunoneutralization of the common ß-subunit. It has
also been shown that an MAB directed against CD11b/CD18 largely
abolishes the oxLDL-induced leukocyte rolling and adherence observed in
hamster dorsal skinfold arterioles and postcapillary
venules.8 Our findings with a CD18-specific MAB in rat
mesenteric venules confirm these published in vitro and in vivo
observations with oxLDL and support the view that the
ß2-integrins on leukocytes are an important determinant
of the leukocyte adherence and emigration elicited by oxLDL.
Along with the antibodies directed against CD11/CD18, we tested the synthetic peptide F20 that was derived from the FHA of B. pertussis.9 This peptide contains the cell adhesion motif RGD, which on FHA is believed to interact with a leukocyte signal-transduction complex consisting of LRI and IAP.10 11 12 13 14 15 Some evidence suggests that this interaction modulates CD11b/CD18 activity and facilitates FHA-mediated bacterial binding to monocytes via this ß2-integrin.10 11 12 Recently, we9 demonstrated in vitro that peptide F20 could inhibit neutrophil adherence and transendothelial migration in response to tumor necrosis factor stimulation of endothelial cells. In experimental meningitis in rabbits, in which the CD18 integrins have been shown to be critically involved in leukocyte recruitment into the central nervous system,35 F20 administration significantly reduced cerebrospinal fluid leukocytosis.9 Additionally, in a rat model of transient middle cerebral artery occlusion,36 F20 administration significantly reduced ischemic cell damage and inhibited neutrophil influx into the ischemic brain lesion, with no detectable effect on the number of circulating leukocytes. Our finding in the present study that peptide F20 significantly inhibits leukocyte adherence to endothelial cells supports the notion that CD11b/CD18 plays a role in the leukocyte inflammatory response provoked by oxLDL.
The results of the present study also invoke a role for another leukocyte adhesion glycoprotein in oxLDL-induced leukocyte recruitment, ie, L-selectin. We observed that an L-selectin MAB reduced leukocyte adherence and emigration by 55% to 60%, which was less than the inhibition (80% to 85%) afforded by a CD18 MAB, suggesting that CD11/CD18 makes a larger contribution to this recruitment process. The available data in the literature suggest that L-selectin likely contributes to oxLDL-induced leukocyte recruitment by mediating the low-affinity leukocyte rolling that precedes the firm attachment of leukocytes to endothelial cells.23 It has been shown37 that soon after activation of leukocytes, L-selectin mediates rolling and then is shed from the leukocyte surface. Indeed, it has been shown38 that incubation of isolated neutrophils with oxLDL results in the shedding of L-selectin from the neutrophil surface. The observation that the L-selectin MAB does not significantly attenuate the oxLDL-induced leukocyte rolling and does not reduce leukocyte adherence/emigration to the same level (assuming rolling is a prerequisite for firm adherence and emigration) as a CD18-specific MAB suggests that additional adhesion molecules are likely to participate in oxLDL-induced leukocyte rolling.
Our findings indicate that two endothelial cellassociated adhesion molecules contribute to oxLDL-induced leukocyte recruitment in postcapillary venules, ie, P-selectin and ICAM-1. P-selectin, which mediates leukocyte rolling in vivo,39 is present in Weibel-Palade bodies internalized within endothelial cells and can be rapidly (5 to 10 minutes) translocated to the cell surface, where it can exert an adhesive action. Recently, it has been reported40 that oxLDL causes a prolonged (>1 hour) increase in P-selectin expression on cultured human umbilical vein endothelial cells. Our observation that P-selectin MABs are effective in attenuating oxLDL-induced leukocyte adherence and emigration but not leukocyte rolling in postcapillary venules are consistent with previous studies7 suggesting that leukocytes may roll on unidentified molecules other than P-selectin and L-selectin. Nevertheless, the results of the present study support a role for increased P-selectin expression in leukocyte adhesion and emigration in microvessels exposed to oxLDL.
The level of constitutive expression of ICAM-1 on endothelial cells in most tissues is quite high.41 This adhesion glycoprotein, which serves as a counterreceptor for CD11/CD18 on leukocytes, has been implicated in the firm adhesion and emigration of leukocytes observed in several models of inflammation.26 42 43 The present study provides the first evidence that invokes a role for ICAM-1 in oxLDL-induced leukocyte rolling and adhesion in postcapillary venules. Because ICAM-1 requires 2 to 3 hours for significant increases in surface expression after endothelial cell activation,44 it is likely that constitutively expressed ICAM-1 participates in oxLDL-induced leukocyte recruitment by serving as a ligand for the CD11/CD18 that is expressed on the surface of activated leukocytes. Although it remains unclear whether oxLDL can elicit an increased expression of ICAM-1 on endothelial cells, preliminary studies in our laboratory indicate that oxLDL does not increase ICAM-1 expression on endothelial cells in the gut up to 5 hours after systemic administration, which is consistent with the responses noted for cultured endothelial cells exposed to minimally oxidized LDL.45 However, it has also been reported that exposure of porcine coronary arteries to oxLDL induces ICAM-1 expression, with an accompanying increase in neutrophil adhesion.46 Furthermore, in another study,47 it was shown that oxLDL enhances tumor necrosis factorinduced ICAM-1 expression in cultured human aortic endothelial cells.
Previous work in our laboratory5 demonstrated that local intra-arterial infusion of oxLDL elicits an increased albumin leakage in postcapillary venules of rat mesentery. Our findings with MABs directed against different leukocyte and endothelial cell adhesion molecules provide new insight concerning the contribution of leukocyte adhesion to the endothelial barrier dysfunction elicited by oxLDL. The results of the present study clearly demonstrate that the vascular leakage response to oxLDL is significantly blunted by treatment with MABs directed against either CD18, ICAM-1, or P-selectin but not L-selectin or a nonbinding MAB. Overall, these observations are consistent with previous reports25 showing a strong positive correlation between the magnitude of the albumin leakage response and the number of adherent and emigrated leukocytes in mesenteric venules. Hence, our findings indicate that the firm adhesion and/or emigration of leukocytes across venular endothelium is a requirement for the enhanced albumin extravasation elicited by oxLDL.
Although most of the binding MABs to adhesion molecules were effective in reducing both leukocyte adherence/emigration and albumin leakage, the MAB directed against L-selectin only affected the adhesion responses. Although a definitive explanation for the inability of L-selectin to inhibit the albumin leakage response is not readily available, it may be related to oxLDL-induced mast cell degranulation. An interesting and novel observation in the present study was the ability of different adhesion moleculespecific MABs and peptide F20 to attenuate oxLDL-induced mast cell degranulation. Mast cells are known to release a variety of substances, including platelet-activating factor, histamine, leukotrienes, and superoxide anion, each of which can elicit leukocyteendothelial cell adhesion and vascular protein leakage.48 The demonstration that adhesion moleculespecific MABs and peptide F20, which is believed to modulate CD11b/CD18 activity, all blunt mast cell degranulation suggests that adherent or emigrated leukocytes release substances that promote mast cell degranulation. Therefore, it is conceivable that products of mast cell degranulation that are released in response to leukocyte recruitment account for the increased albumin leakage. This could explain why the L-selectin MAB, which did not attenuate oxLDL-induced mast cell degranulation, also does not blunt the albumin leakage response.
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
Dr Starzyk's current address is Genetics Institute, Inc, 87 Cambridge Park Dr, Cambridge, MA 02140.
Received March 31, 1996; accepted July 12, 1996.
| References |
|---|
|
|
|---|
m,ß2, CD11b/CD18) binds filamentous
hemagglutinin of Bordetella pertussis.
Cell. 1990;61:1375-1382. [Medline]
[Order article via Infotrieve]
This article has been cited by other articles:
![]() |
O. Quehenberger Thematic Review Series: The Immune System and Atherogenesis. Molecular mechanisms regulating monocyte recruitment in atherosclerosis J. Lipid Res., August 1, 2005; 46(8): 1582 - 1590. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Sedgwick, Y. S. Hwang, H. A. Gerbyshak, H. Kita, and W. W. Busse Oxidized Low-Density Lipoprotein Activates Migration and Degranulation of Human Granulocytes Am. J. Respir. Cell Mol. Biol., December 1, 2003; 29(6): 702 - 709. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. A. van Haaren, E. VanBavel, H. Vink, and J. A. E. Spaan Localization of the permeability barrier to solutes in isolated arteries by confocal microscopy Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2848 - H2856. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Constantinescu, H. Vink, and J. A.E. Spaan Endothelial Cell Glycocalyx Modulates Immobilization of Leukocytes at the Endothelial Surface Arterioscler. Thromb. Vasc. Biol., September 1, 2003; 23(9): 1541 - 1547. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Alvarez and M.-J. Sanz Reactive oxygen species mediate angiotensin II-induced leukocyte-endothelial cell interactions in vivo J. Leukoc. Biol., August 1, 2001; 70(2): 199 - 206. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Chavakis, E. Dernbach, C. Hermann, U. F. Mondorf, A. M. Zeiher, and S. Dimmeler Oxidized LDL Inhibits Vascular Endothelial Growth Factor-Induced Endothelial Cell Migration by an Inhibitory Effect on the Akt/Endothelial Nitric Oxide Synthase Pathway Circulation, April 24, 2001; 103(16): 2102 - 2107. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Y. Stokes, E. C. Clanton, J. M. Russell, C. R. Ross, and D. N. Granger NAD(P)H Oxidase-Derived Superoxide Mediates Hypercholesterolemia-Induced Leukocyte-Endothelial Cell Adhesion Circ. Res., March 16, 2001; 88(5): 499 - 505. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Mori, Y. Horie, Y. Nimura, R. Wolf, and D. N. Granger Hepatic microvascular responses to ischemia-reperfusion in low-density lipoprotein receptor knockout mice Am J Physiol Gastrointest Liver Physiol, December 1, 2000; 279(6): G1257 - G1264. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Mehrabi, H. Sinzinger, C. Ekmekcioglu, F. Tamaddon, K. Plesch, H. D Glogar, G. Maurer, T. Stefenelli, and I. M. Lang Accumulation of oxidized LDL in human semilunar valves correlates with coronary atherosclerosis Cardiovasc Res, March 1, 2000; 45(4): 874 - 882. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Johnson, C. L. Jackson, G. D. Angelini, and S. J. George Activation of Matrix-Degrading Metalloproteinases by Mast Cell Proteases in Atherosclerotic Plaques Arterioscler. Thromb. Vasc. Biol., November 1, 1998; 18(11): 1707 - 1715. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |